Effects of Lixisenatide Versus Liraglutide (Short- and Long-Acting GLP-1 Receptor Agonists) on Esophageal and Gastric Function in Patients With Type 2 Diabetes.

Daniel Robert QuastNina SchenkerBjörn A MengeMichael A NauckChristoph KapitzaJuris J Meier

Published in: Diabetes care (2020)

Lixisenatide exerted a more pronounced influence on gastric emptying after breakfast than liraglutide. Neither lixisenatide nor liraglutide had significant effects on esophageal reflux or motility. Gastric acid secretion appears to be slightly reduced by GLP-1 RAs.

Keyphrases

biofilm formation
escherichia coli
staphylococcus aureus
cystic fibrosis
pseudomonas aeruginosa